168 related articles for article (PubMed ID: 36400533)
1. Genetic Modifiers of Sickle Cell Disease.
Pincez T; Ashley-Koch AE; Lettre G; Telen MJ
Hematol Oncol Clin North Am; 2022 Dec; 36(6):1097-1124. PubMed ID: 36400533
[TBL] [Abstract][Full Text] [Related]
2. Genetic Variation and Sickle Cell Disease Severity: A Systematic Review and Meta-Analysis.
Kirkham JK; Estepp JH; Weiss MJ; Rashkin SR
JAMA Netw Open; 2023 Oct; 6(10):e2337484. PubMed ID: 37851445
[TBL] [Abstract][Full Text] [Related]
3. Genetic Modifiers of Fetal Haemoglobin in Sickle Cell Disease.
Menzel S; Thein SL
Mol Diagn Ther; 2019 Apr; 23(2):235-244. PubMed ID: 30478714
[TBL] [Abstract][Full Text] [Related]
4. The search for genetic modifiers of disease severity in the β-hemoglobinopathies.
Lettre G
Cold Spring Harb Perspect Med; 2012 Oct; 2(10):. PubMed ID: 23028136
[TBL] [Abstract][Full Text] [Related]
5. Genetic association studies in β-hemoglobinopathies.
Thein SL
Hematology Am Soc Hematol Educ Program; 2013; 2013():354-61. PubMed ID: 24319204
[TBL] [Abstract][Full Text] [Related]
6. Original Research: A case-control genome-wide association study identifies genetic modifiers of fetal hemoglobin in sickle cell disease.
Liu L; Pertsemlidis A; Ding LH; Story MD; Steinberg MH; Sebastiani P; Hoppe C; Ballas SK; Pace BS
Exp Biol Med (Maywood); 2016 Apr; 241(7):706-18. PubMed ID: 27022141
[TBL] [Abstract][Full Text] [Related]
7. Minireview: Genetic basis of heterogeneity and severity in sickle cell disease.
Habara A; Steinberg MH
Exp Biol Med (Maywood); 2016 Apr; 241(7):689-96. PubMed ID: 26936084
[TBL] [Abstract][Full Text] [Related]
8. Genetic Basis and Genetic Modifiers of β-Thalassemia and Sickle Cell Disease.
Thein SL
Adv Exp Med Biol; 2017; 1013():27-57. PubMed ID: 29127676
[TBL] [Abstract][Full Text] [Related]
9. Heritability of fetal hemoglobin, white cell count, and other clinical traits from a sickle cell disease family cohort.
Bao EL; Lareau CA; Brugnara C; Fulcher IR; Barau C; Moutereau S; Habibi A; Badaoui B; Berkenou J; Bartolucci P; Galactéros F; Platt OS; Mahaney M; Sankaran VG
Am J Hematol; 2019 May; 94(5):522-527. PubMed ID: 30680775
[TBL] [Abstract][Full Text] [Related]
10. Genetic variants associated with fetal hemoglobin levels show the diverse ethnic origin in Colombian patients with sickle cell anemia.
Fong C; Menzel S; Lizarralde MA; Barreto G
Biomedica; 2015; 35(3):437-43. PubMed ID: 26849705
[TBL] [Abstract][Full Text] [Related]
11. DNA polymorphisms at the BCL11A, HBS1L-MYB, and beta-globin loci associate with fetal hemoglobin levels and pain crises in sickle cell disease.
Lettre G; Sankaran VG; Bezerra MA; Araújo AS; Uda M; Sanna S; Cao A; Schlessinger D; Costa FF; Hirschhorn JN; Orkin SH
Proc Natl Acad Sci U S A; 2008 Aug; 105(33):11869-74. PubMed ID: 18667698
[TBL] [Abstract][Full Text] [Related]
12. Identifying genetic variants and pathways associated with extreme levels of fetal hemoglobin in sickle cell disease in Tanzania.
Nkya S; Mwita L; Mgaya J; Kumburu H; van Zwetselaar M; Menzel S; Mazandu GK; Sangeda R; Chimusa E; Makani J
BMC Med Genet; 2020 Jun; 21(1):125. PubMed ID: 32503527
[TBL] [Abstract][Full Text] [Related]
13. Genetic modifiers of sickle cell disease.
Steinberg MH; Sebastiani P
Am J Hematol; 2012 Aug; 87(8):795-803. PubMed ID: 22641398
[TBL] [Abstract][Full Text] [Related]
14. Genetic Modifiers of Stroke in Patients with Sickle Cell Disease-A Scoping Review.
Oni MO; Brito M; Rotman C; Archer NM;
Int J Mol Sci; 2024 Jun; 25(12):. PubMed ID: 38928024
[TBL] [Abstract][Full Text] [Related]
15. [Genetic modifiers of homozygous sickle cell disease].
Hartmann K; Kulozik AE
Klin Padiatr; 2006; 218(3):170-3. PubMed ID: 16688674
[TBL] [Abstract][Full Text] [Related]
16. Genetic modifiers of HbF and response to hydroxyurea in sickle cell disease.
Green NS; Barral S
Pediatr Blood Cancer; 2011 Feb; 56(2):177-81. PubMed ID: 20830771
[TBL] [Abstract][Full Text] [Related]
17. The Genetic and Clinical Significance of Fetal Hemoglobin Expression in Sickle Cell Disease.
Adekile A
Med Princ Pract; 2021; 30(3):201-211. PubMed ID: 32892201
[TBL] [Abstract][Full Text] [Related]
18. Genetic variants at HbF-modifier loci moderate anemia and leukocytosis in sickle cell disease in Tanzania.
Mtatiro SN; Makani J; Mmbando B; Thein SL; Menzel S; Cox SE
Am J Hematol; 2015 Jan; 90(1):E1-4. PubMed ID: 25263325
[TBL] [Abstract][Full Text] [Related]
19. Genomic polymorphisms in sickle cell disease: implications for clinical diversity and treatment.
Fertrin KY; Costa FF
Expert Rev Hematol; 2010 Aug; 3(4):443-58. PubMed ID: 21083035
[TBL] [Abstract][Full Text] [Related]
20. Roles of APOL1 G1 and G2 variants in sickle cell disease patients: kidney is the main target.
Kormann R; Jannot AS; Narjoz C; Ribeil JA; Manceau S; Delville M; Joste V; Prié D; Pouchot J; Thervet E; Courbebaisse M; Arlet JB
Br J Haematol; 2017 Oct; 179(2):323-335. PubMed ID: 28699644
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
